1-{3-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-propyl}-1,3-dihydro-benzoimidazol-2-one | 84243-00-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并异恶唑
• 英文名称: 1-{3-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-propyl}-1,3-dihydro-benzoimidazol-2-one
• 英文别名: 3-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propyl]-1H-benzimidazol-2-one
• CAS: 84243-00-5
• 化学式: C₂₂H₂₃FN₄O₂
• 分子量: 394.449
• InChiKey: QUIARMAKZRZBJK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  29
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  61.6
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  6-fluoro-3-(1-formyl-4-piperidinyl)-1,2-benzisoxazole 在 盐酸 、 sodium carbonate 、 potassium iodide 作用下， 以 乙醇 为溶剂， 反应 15.0h， 生成 1-{3-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-propyl}-1,3-dihydro-benzoimidazol-2-one
  参考文献：
  名称：

  Synthesis and neuroleptic activity of 3-(1-substituted-4-piperidinyl)-1,2-benzisoxazoles

  摘要：

  The synthesis of a series of 3-(1-substituted-4-piperidinyl)-1,2-benzisoxazoles is described. The neuroleptic activity of the series was evaluated by utilizing the climbing mice assay and inhibition of [3H]spiroperidol binding. Structure-activity relationships were studied by variation of the substituent on the benzisoxazole ring with concomitant variation of four different 1-piperidinyl substituents. Maximum neuroleptic activity was realized when there was a 6-fluoro substituent on the benzisoxazole ring. The 1-piperidinyl substituent appeared less significant, although in most cases, the (1,3-dihydro-2-oxo-2H-benzimidazol-1-yl)propyl group imparted maximum potency. The most potent compound in both assays was 6-fluoro-3-[1-[3-(1,3-dihydro-2-oxo-2H-benzimidazol-1-yl) propyl]-4-piperidinyl]-1,2-benzisoxazole (11b).

  DOI：

  10.1021/jm00383a012

文献信息

• 3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles, a process for the preparation thereof, a pharmaceutical composition comprising the same, and their use as medicaments
  申请人：HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED

  公开号：EP0079564A1

  公开（公告）日：1983-05-25

  Novel 3-(1-substituted-4-piperidyl)-1,2-benzisoxazoles, of the formula 1 wherein X is halogen, loweralkyl, loweralkoxy or hydroxy and m is 0, 1 or 2, R is a group of the formula wherein n is 2 or 3; a group of the formula wherein n is 2 or 3; a group of the formula wherein n is 2 or 3; a group of the formula wherein R, and R2 are each independently hydrogen or loweralkyl, R3 is hydrogen, halogen or loweralkyl and n is 2 or 3: a group of the formula wherein R4 is hydrogen or loweralkyl, R5 is hydrogen, halogen or loweralkyl; and n is 2 or 3; and a group of the formula the optical antipodes thereof; or pharmaceutically acceptable acid addition salts thereof. processes for the preparation thereof, their use for treating psychoses and compositions thereof are disclosed.

  式 1 的新型 3-(1-取代-4-哌啶基)-1,2-苯并异噁唑 其中 X 为卤素、低级烷基、低级烷氧基或羟基，m 为 0、1 或 2，R 为式中的基团 式中 n 为 2 或 3 的基团 式中 n 为 2 或 3 的基团 式中 n 为 2 或 3 的基团 其中 R 和 R2 各自独立地为氢或低级烷基，R3 为氢、卤素或低级烷基，且 n 为 2 或 3 的式子的基团 其中 R4 是氢或低级烷基，R5 是氢、卤素或低级烷基，且 n 是 2 或 3；以及式中的基团 其光学反义词；或其药学上可接受的酸加成盐。 公开了其制备工艺、治疗精神病的用途及其组合物。
• STRUPCZEWSKI, J. T.;ALLEN, R. C.;GARDNER, B. A.;SCHMID, B. L.;STACHE, U.;+, J. MED. CHEM., 1985, 28, N 6, 761-769
  作者：STRUPCZEWSKI, J. T.、ALLEN, R. C.、GARDNER, B. A.、SCHMID, B. L.、STACHE, U.、+

  DOI：——

  日期：——
• US4352811A
  申请人：——

  公开号：US4352811A

  公开（公告）日：1982-10-05
• Synthesis and neuroleptic activity of 3-(1-substituted-4-piperidinyl)-1,2-benzisoxazoles
  作者：Joseph T. Strupczewski、Richard C. Allen、Beth Ann Gardner、Blaine L. Schmid、Ulrich Stache、Edward J. Glamkowski、Michael C. Jones、Daniel B. Ellis、Francis P. Huger、Robert W. Dunn

  DOI：10.1021/jm00383a012

  日期：1985.6

  The synthesis of a series of 3-(1-substituted-4-piperidinyl)-1,2-benzisoxazoles is described. The neuroleptic activity of the series was evaluated by utilizing the climbing mice assay and inhibition of [3H]spiroperidol binding. Structure-activity relationships were studied by variation of the substituent on the benzisoxazole ring with concomitant variation of four different 1-piperidinyl substituents. Maximum neuroleptic activity was realized when there was a 6-fluoro substituent on the benzisoxazole ring. The 1-piperidinyl substituent appeared less significant, although in most cases, the (1,3-dihydro-2-oxo-2H-benzimidazol-1-yl)propyl group imparted maximum potency. The most potent compound in both assays was 6-fluoro-3-[1-[3-(1,3-dihydro-2-oxo-2H-benzimidazol-1-yl) propyl]-4-piperidinyl]-1,2-benzisoxazole (11b).